Kearney, Neb., June 13, 2017-In 2018, the Bridging Clinical Research and Clinical Health Care Collaborative will bring together industry leaders from pharma, biotech, clinical research organizations, health care organizations, advocacy groups, and the FDA to advance the participation of patients and physicians in the conduct of clinical trials. The conference will be April 4–5 at the Gaylord National Resort and Conference Center in National Harbor, MD.
“Poor recruitment is the leading cause of failure in clinical trials. Less than 3 percent of patients and physicians participate,” said Cinda Orr, president and CEO of SCORR Marketing. “For quite some time, I have watched our industry try to determine how we can change this, but we have not made significant progress. As I am passionate about helping patients, I have established the Bridging Clinical Research and Clinical Health Care Collaborative with the support from health science colleagues and organizations so we can actualize a solution.”
The keynote speaker for the conference is Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration. Representing patients will be T.J. Sharpe, cancer survivor and patient advocate. Additional speakers have already been scheduled from 2bPrecise, Allscripts, HCA Healthcare, IBM Watson Health, INC Research and Sarah Cannon. Elligo Health Research, Allscripts, and INC Research are sponsors andApplied Clinical Trials, CenterWatch and FierceBiotech are media partners.
